46,369 Shares in Semler Scientific Inc. $SMLR Purchased by Pinnacle Wealth Management LLC

Key Points

• Pinnacle Wealth Management LLC acquired 46,369 shares of Semler Scientific Inc. for approximately $1.8 million, representing about 0.34% of the company's stock.
• Several hedge funds, including Charles Schwab Investment Management and Interchange Capital Partners, have also increased their stakes in Semler Scientific, highlighting a growing institutional interest.
• Equities analysts have reduced their price targets for Semler Scientific, with an average target now at $74.25 and a rating of "Moderate Buy."

Pinnacle Wealth Management LLC purchased a new position in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 46,369 shares of the company's stock, valued at approximately $1,796,000. Pinnacle Wealth Management LLC owned approximately 0.34% of Semler Scientific as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of SMLR. Interchange Capital Partners LLC acquired a new position in Semler Scientific in the first quarter worth about $46,502,000. Charles Schwab Investment Management Inc. grew its stake in Semler Scientific by 226.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company's stock worth $5,740,000 after purchasing an additional 109,951 shares in the last quarter. Generali Asset Management SPA SGR acquired a new position in Semler Scientific in the second quarter worth about $2,712,000. Deltec Asset Management LLC grew its stake in Semler Scientific by 112.0% in the second quarter. Deltec Asset Management LLC now owns 100,932 shares of the company's stock worth $3,910,000 after purchasing an additional 53,332 shares in the last quarter. Finally, Pacer Advisors Inc. acquired a new position in Semler Scientific in the first quarter worth about $1,874,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Cantor Fitzgerald decreased their price target on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Benchmark decreased their price target on Semler Scientific from $101.00 to $86.00 and set a "buy" rating for the company in a research note on Tuesday, September 23rd. Maxim Group decreased their price target on Semler Scientific from $95.00 to $80.00 and set a "buy" rating for the company in a research note on Friday, September 19th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Semler Scientific in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $74.25.

Semler Scientific Stock Performance

Shares of NASDAQ SMLR opened at $23.18 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.60 and a debt-to-equity ratio of 0.25. The firm's 50-day moving average price is $29.79 and its two-hundred day moving average price is $34.33. Semler Scientific Inc. has a 52-week low of $22.59 and a 52-week high of $81.56. The stock has a market capitalization of $350.95 million, a P/E ratio of 9.54 and a beta of 1.41.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $5.31. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%. The firm had revenue of $8.22 million for the quarter, compared to analysts' expectations of $8.10 million.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific Inc. (NASDAQ:SMLR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.